Thu, January 19, 2023

Silvan Tuerkcan Maintained (VOR) at Buy with Decreased Target to $12 on, Jan 19th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-12-on-jan-19th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Silvan Tuerkcan of JMP Securities, Maintained "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $15 to $12 on, Jan 19th, 2023.

Silvan has made no other calls on VOR in the last 4 months.



There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 0 agree with Silvan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Silvan


  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $18 on, Monday, November 14th, 2022
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $15 on, Friday, November 11th, 2022